Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 9/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30099552 | 0.97 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30099553 | 0.97 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30546898 | 0.97 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30637048 | 0.92 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL31326252 | 0.90 | TERT (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29425540 | 0.90 | TERT (0.41) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30585206 | 0.88 | ALDH1A1 (0.46) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30585205 | 0.88 | ALDH1A1 (0.46) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30585204 | 0.88 | ALDH1A1 (0.46) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL11253834 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692103-A1 | NOVEL TARGETING COMPOUND AND USE THEREOF, AND NUCLEIC ACID CONJUGATE AND USE THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2026-02-11 | — | — | EP | claimed |
| US-20250282838-A1 | Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease | OTHAIR PROTHENA LIMITED (IE) | 2025-09-11 | — | — | US | claimed |
| US-20250186567-A1 | MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | OTHAIR PROTHENA LTD (IE) | 2025-06-12 | — | — | US | claimed |
| US-12247056-B2 | Multi-epitope vaccine for the treatment of Alzheimer's disease | OTHAIR PROTHENA LIMITED (IE) | 2025-03-11 | — | — | US | claimed |
| WO-2024230763-A1 | NOVEL TARGETING COMPOUND AND USE THEREOF, AND NUCLEIC ACID CONJUGATE AND USE THEREOF | 广东东阳光药业股份有限公司 | 2024-11-14 | — | — | WO | claimed |
| CN-118930593-A | Novel targeting compounds and nucleic acid conjugates and uses thereof | 广东东阳光药业股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| US-20240343769-A1 | Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease | OTHAIR PROTHENA LIMITED (IE) | 2024-10-17 | — | — | US | claimed |
| US-11965005-B2 | Multi-epitope vaccine for the treatment of Alzheimer's disease | OTHAIR PROTHENA LIMITED (IE) | 2024-04-23 | — | — | US | claimed |
| US-11952406-B2 | Multi-epitope vaccine for the treatment of Alzheimer's disease | OTHAIR PROTHENA LIMITED (IE) | 2024-04-09 | — | — | US | claimed |
| US-11945849-B2 | Multi-epitope vaccine for the treatment of Alzheimer's disease | OTHAIR PROTHENA LIMITED (IE) | 2024-04-02 | — | — | US | claimed |
| EP-4213941-A1 | MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | OTHAIR PROTHENA LIMITED (IE) | 2023-07-26 | — | — | EP | claimed |
| CN-116472055-A | Multi-epitope vaccine for treating Alzheimer's disease | 欧萨尔普罗席纳有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116438191-A | Multi-epitope vaccine for treating Alzheimer's disease | 欧萨尔普罗席纳有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-20230183304-A1 | Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease | PROTHENA BIOSCIENCES INC | 2023-06-15 | — | — | US | claimed |
| EP-4192497-A1 | MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | OTHAIR PROTHENA LIMITED (IE) | 2023-06-14 | — | — | EP | claimed |
| CN-115867304-A | Multi-epitope vaccine for treating alzheimer's disease | 欧萨尔普罗席纳有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-115697420-A | Method and medicine for treating herler's syndrome | 北京辑因医疗科技有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-11506662-B2 | Detection, identification, and purification of degradative and non-degradative enzymes in biological samples | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-11-22 | — | — | US | claimed |
| CN-113528582-B | Method and medicine for targeted editing of RNA based on LEAPER technology | 博雅辑因（北京）生物科技有限公司 | 2022-05-17 | — | — | CN | claimed |
| WO-2022060488-A1 | MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | OTHAIR PROTHENA LIMITED (IE) | 2022-03-24 | — | — | WO | claimed |